Genomics Reveal Potential Biomarkers of Response to Pembrolizumab after High Dose Cytarabine in an Ongoing Phase II Trial in Relapsed/Refractory AML
- Resource Type
- Abstract
- Authors
- Zeidner, Joshua F; Vincent, Benjamin G.; Ivanova, Anastasia ; Foster, Matthew C; Coombs, Catherine C.; Jamieson, Katarzyna ; Van Deventer, Hendrik W.; Blanchard, Laura ; Frank, Cassiopeia ; Gallagher, Sean ; Matson, Melissa ; Pepin, Katherine ; Vaught, Lori ; Vogler, Nancy ; Miller, Kelsey ; Betts, Laurie ; McKinnon, Karen ; Bortone, Dante S. ; Parker, Joel S. ; Luznik, Leo; Gojo, Ivana; Serody, Jonathan S
- Source
- In Blood 29 November 2018 132 Supplement 1:4054-4054
- Subject
- Language
- ISSN
- 0006-4971